InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,732.93
(
0.25%
)
US TECH 100
19,426.00
(
0.54%
)
Dow Jones
42,208.22
(
0.20%
)
Brent Oil
74.58
(
0.02%
)
Bitcoin
64,191.88
(
-0.12%
)
Post# of 12660
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120491
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: makedrysgreatagain post# 12657

Wednesday, 05/22/2019 11:17:37 AM

Wednesday, May 22, 2019 11:17:37 AM

Post# of 12660
Hi. There are several approved drugs approved for prostate cancer that were not available when Provenge was launched about ten years ago. Before making a treatment decision, any cancer patient should consider getting a genetic screen such as FoundationOne CDx (https://www.foundationmedicine.com/genomic-testing/foundation-one-cdx ), which is offered by Foundation Medicine, a subsidiary of Roche.

Good luck. Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up